Stockholders' Equity - Other (Details) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2022 USD ($) item $ / shares shares	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($) item $ / shares shares	Jun. 30, 2021 USD ($)	Dec. 31, 2021 $ / shares shares	Jan. 01, 2022	May 25, 2021 shares
Stockholders' Equity
Shares available for issuance	2,900		2,900
Stock-based compensation
Stock-based compensation expense (in dollars) | $	$ 800	$ 1,500	$ 2,200	$ 2,800
Estimated forfeitures (as a percent)						1.50%
Historical forfeitures (as a percent)						2.60%
Restricted Stock
Stock-based compensation
Unrecognized compensation cost related to unvested restricted stock (in dollars) | $	$ 3,700		$ 3,700
Weighted-average periods over which unrecognized compensation cost recognized			1 year 9 months 18 days
Number of shares
Outstanding at the beginning of the period (in shares)			614
Granted (in shares)			285
Vested (in shares)			(329)
Forfeited (in shares)			(59)
Outstanding at the end of the period (in shares)	511		511		614
Weighted-average grant date fair value
Outstanding at the beginning of the period (in dollars per share) | $ / shares			$ 11.79
Granted (in dollars per share) | $ / shares			6.09
Vested (in dollars per share) | $ / shares			12.09
Forfeited (in dollars per share) | $ / shares			12.00
Outstanding at the end of the period (in dollars per share) | $ / shares	$ 8.40		$ 8.40		$ 11.79
Employee Stock Options
Stock-based compensation
Unrecognized compensation cost related to unvested stock options (in dollars) | $	$ 2,200		$ 2,200
Weighted-average periods over which unrecognized compensation cost recognized			1 year 10 months 24 days
Number of shares
Outstanding at the beginning of the period (in shares)			4,445
Granted (in shares)			105
Forfeited (in shares)			(182)
Expired (in shares)			(8)
Outstanding at the end of the period (in shares)	4,360		4,360		4,445
Vested at the end of the period (in shares)	3,785		3,785
Exercisable at the end of the period (in shares)	3,785		3,785
Weighted-average exercise price
Outstanding at the beginning of the period (in dollars per share) | $ / shares			$ 11.69
Granted (in dollars per share) | $ / shares			5.44
Forfeited (in dollars per share) | $ / shares			11.55
Expired (in dollars per share) | $ / shares			10.39
Outstanding at the end of the period (in dollars per share) | $ / shares	$ 11.55		11.55		$ 11.69
Vested at the end of the period (in dollars per share) | $ / shares	11.69		11.69
Exercisable at the end of the period (in dollars per share) | $ / shares	$ 11.69		$ 11.69
Weighted-average remaining contractual term
Outstanding			4 years 3 months 18 days		4 years 9 months 18 days
Granted			6 years
Vested at the end of the period			3 years 7 months 6 days
Exercisable at the end of the period			3 years 7 months 6 days
Aggregate intrinsic value
Outstanding at the end of the period (in dollars) | $	$ 221		$ 221
Weighted-average grant date fair value of options granted (in dollars per share) | $ / shares			$ 2.26
Performance-based Stock Option
Number of shares
Unvested options	300		300
Performance-based Restricted Stock
Aggregate intrinsic value
Vesting period			3 years
Time Based Restricted Stock and Stock Option
Stockholders' Equity
Number of equal annual installments for vesting of awards | item	3		3
Time Based Restricted Stock and Stock Option | Black Scholes Pricing Model
Valuation assumptions
Risk-free interest rate (as a percent)			1.93%
Volatility (as a percent)			40.40%
Weighted-average expected term (years)			6 years		6 years
Time Based Restricted Stock and Stock Option | Minimum | Black Scholes Pricing Model
Valuation assumptions
Risk-free interest rate (as a percent)					0.94%
Volatility (as a percent)					37.30%
Time Based Restricted Stock and Stock Option | Maximum | Black Scholes Pricing Model
Valuation assumptions
Risk-free interest rate (as a percent)					1.29%
Volatility (as a percent)					40.70%
Time Based Restricted Stock
Aggregate intrinsic value
Vesting period			3 years
Common Class A
Stockholders' Equity
Shares authorized for issuance							10,200